重庆山外山血液净化技术股份有限公司 2025年第三季度报告

Group 1 - The company has guaranteed the authenticity, accuracy, and completeness of the quarterly report, and assumes legal responsibility for any false records or misleading statements [2][3][4] - The company will not conduct an audit for the third-quarter financial statements [3][8] - The company has approved the repurchase and cancellation of 1,715,024 shares from the 2024 employee stock ownership plan due to unmet performance conditions [5][6] Group 2 - The company has proposed to appoint Tianzhi International Accounting Firm as the auditor for the 2025 fiscal year, pending approval from the shareholders' meeting [10][17][19] - Tianzhi International has a strong background in audit services, with a total revenue of 2.501 billion yuan in 2024, including 1.938 billion yuan from audit services [11][14] - The company plans to use up to 1 billion yuan of idle funds for cash management, focusing on safe and liquid financial products [27][32][36]